

1,401,923 filings since 2004 · latest accepted Nov 3, 2026, 5:27 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Oct 1, 2026 accepted 6:09 PM ET | CNBXCNBX Pharmaceuticals Inc. | 4.01Auditor change | DocumentSEC ↗ |
Mar 17, 2026 accepted 12:30 PM ET | CNBXCNBX Pharmaceuticals Inc. | 1.01Material agreement | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Jan 30, 2025 accepted 12:12 AM ET | CNBXCNBX Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Mar 22, 2024 accepted 12:51 PM ET | CNBXCNBX Pharmaceuticals Inc. | 4.01Auditor change | DocumentSEC ↗ |
Feb 8, 2023 accepted 12:50 PM ET | CNBXCNBX Pharmaceuticals Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Dec 29, 2022 accepted 7:51 PM ET | CNBXCNBX Pharmaceuticals Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jul 25, 2022 accepted 4:11 PM ET | CNBXCNBX Pharmaceuticals Inc. | 5.02Officer / director change | DocumentSEC ↗ |
May 13, 2022 accepted 8:31 PM ET | CNBXCNBX Pharmaceuticals Inc. | 5.03Bylaws / fiscal year | DocumentSEC ↗ |
Mar 28, 2022 accepted 9:00 PM ET | CNBXCNBX Pharmaceuticals Inc. | 5.03Bylaws / fiscal year8.01Other events | DocumentSEC ↗ |
Mar 16, 2022 accepted 9:57 PM ET | CNBXCNBX Pharmaceuticals Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |
Feb 17, 2022 accepted 1:30 PM ET | CNBXCNBX Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Nov 19, 2021 accepted 7:51 PM ET | CNBXCNBX Pharmaceuticals Inc. | 5.02Officer / director change | DocumentSEC ↗ |